Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-21
DOI
10.1007/s00259-021-05374-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- [153Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma
- (2021) Clemens Kratochwil et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Multimodality imaging of adult rhabdomyosarcoma: the added value of hybrid imaging
- (2020) Nicolò Gennaro et al. BRITISH JOURNAL OF RADIOLOGY
- FAPI-74 PET/CT Using Either 18F-AlF or Cold-kit 68Ga-labeling: Biodistribution, Radiation Dosimetry and Tumor Delineation in Lung Cancer Patients
- (2020) Frederik Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodeling
- (2020) J. Siebermair et al. JOURNAL OF NUCLEAR CARDIOLOGY
- Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years
- (2020) Jakob Lochner et al. Oncology Research and Treatment
- Effectiveness of 18F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies
- (2019) Fanxiao Liu et al. BMC CANCER
- FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer
- (2019) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- The role of fibroblast activation protein in progression and development of osteosarcoma cells
- (2019) Liang Zhang et al. CLINICAL AND EXPERIMENTAL MEDICINE
- The impact of 18F-FDG PET on initial staging and therapy planning of pediatric soft-tissue sarcoma patients
- (2019) Alaa Elmanzalawy et al. PEDIATRIC RADIOLOGY
- Targeting fibroblast activation protein in cancer ndash Prospects and caveats
- (2018) Aleksi Sedo Frontiers in Bioscience-Landmark
- Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein
- (2018) Thomas Lindner et al. JOURNAL OF NUCLEAR MEDICINE
- A new method for tumor imaging by targeting cancer associated fibroblasts
- (2018) Anastasia Loktev et al. JOURNAL OF NUCLEAR MEDICINE
- FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers
- (2018) Frederik Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
- (2017) William D Tap et al. LANCET ONCOLOGY
- Dual–time point 18 F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations
- (2017) Rahul V. Parghane et al. SEMINARS IN NUCLEAR MEDICINE
- Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis
- (2015) Fang Liu et al. PLoS One
- Impact of fibroblast activation protein on osteosarcoma cell lines in vitro
- (2014) LIXIANG DING et al. Oncology Letters
- Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma
- (2013) Dongtang Yuan et al. JOURNAL OF SURGICAL ONCOLOGY
- Evaluation of soft-tissue lesions with 18F-FDG PET/CT
- (2013) Aline L. Leal et al. NUCLEAR MEDICINE COMMUNICATIONS
- Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours
- (2009) Osamu Dohi et al. HISTOPATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More